"Prime-Boost Vaccine Schedule for Prevention of HIV Infection"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 26, 2005

Study Completion Date

January 22, 2008

Conditions

HIV Infections

Interventions

DRUG

VRC-HIVDNA016-00-VP

DRUG

VRC-HIVADV014-00

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00109629 - "Prime-Boost Vaccine Schedule for Prevention of HIV Infection" | Biotech Hunter | Biotech Hunter